Vitamin D is not a vitamin in the traditional sense — it is a secosteroid hormone, produced in the skin upon UVB exposure, that acts on vitamin D receptors (VDR) expressed in virtually every cell in the body. VDR activation regulates over 1,000 genes involved in immune function, calcium homeostasis, cell proliferation, inflammation, insulin secretion, and cardiovascular function. Despite this ubiquitous role, 42% of Americans have 25(OH)D levels below 20 ng/mL — the conventional deficiency threshold — and an even higher proportion fall below the 40–60 ng/mL range increasingly considered optimal for non-skeletal health outcomes.
The vitamin D3 + K2 combination is critical because of their shared role in calcium metabolism: vitamin D3 dramatically increases intestinal calcium absorption (by up to 40%), but calcium absorbed without adequate vitamin K2 activity risks depositing in soft tissues — arteries and kidneys — rather than bone. Vitamin K2 (specifically MK-7) activates Matrix Gla Protein (MGP), a potent inhibitor of vascular calcification, and osteocalcin, which directs calcium into bone. The clinical implication: high-dose vitamin D3 without K2 may increase arterial calcification risk — a concern particularly relevant for anyone taking high-dose D3.
| Form | Half-life | Best Sources | Dose | Notes |
|---|---|---|---|---|
| MK-7 (menaquinone-7) | Long (~3 days) | Natto (fermented soybeans — highest K2 food, 1,000 mcg/100g); supplement extracted from natto | 100–200 mcg/day | Preferred supplemental form; long half-life → once-daily dosing achieves stable blood levels; crosses blood-brain barrier; most studied form for cardiovascular outcomes; verify supplement uses all-trans MK-7 (biologically active isomer) |
| MK-4 (menaquinone-4) | Short (~1–2 hours) | Grass-fed butter/ghee, egg yolks, chicken liver, hard cheeses (Gouda, Edam) | Dietary: variable; pharmacological: 1,500–45,000 mcg/day | Short half-life requires 3× daily dosing; at 45mg/day (Japanese osteoporosis trials), significantly improved bone mineral density; most dietary K2 is MK-4; lower supplemental doses (<1mg) may not raise tissue levels meaningfully |
| MK-9, MK-10, MK-11 | Very long | Aged hard cheeses (Gouda, Jarlsberg, aged cheddar); fermented foods | Dietary only | Significant in aged cheeses; longer chain → higher tissue affinity; Beulens 2009: cheese independently associated with lower cardiovascular risk — K2 content hypothesized as mechanism; not in standard supplements |
Step 1 — Test first: Order 25(OH)D blood test before supplementing; available through physician or direct-to-consumer labs (Ulta Lab Tests, LabCorp) without physician order; typical cost $30–50; target: 40–60 ng/mL; retest 3 months after starting to confirm dose adequacy; individual response to D3 varies 3–5× due to genetic differences in VDR binding, CYP enzymes, and vitamin D-binding protein — testing removes the guesswork.
Step 2 — D3 dose: Starting at <20 ng/mL: 5,000 IU D3/day; maintenance at 20–30 ng/mL: 2,000–3,000 IU/day; obese individuals may need 2× the standard dose; take D3 with a fat-containing meal (fat-soluble); use cholecalciferol (D3), not ergocalciferol (D2) — D3 is significantly more effective at raising 25(OH)D levels.
Step 3 — K2 dose: 100–200 mcg/day MK-7 (all-trans form) with D3; take with fat-containing meal; individuals with coronary artery calcium (CAC) score >0: consider 180–360 mcg/day MK-7; warfarin interaction: K2 may reduce anticoagulant effect — always discuss with prescriber if on warfarin; K2 does not significantly affect INR at ≤200 mcg/day in most patients but warfarin requires physician oversight.
Step 4 — Cofactors: Magnesium is required for vitamin D activation (converting 25(OH)D to 1,25(OH)2D, the active hormone) — magnesium deficiency impairs vitamin D conversion even with adequate supplementation; the complete fat-soluble foundation stack: D3 (2,000–5,000 IU) + K2 MK-7 (100–200 mcg) + magnesium glycinate (300–400 mg) — take together with a fat-containing meal; vitamin A (retinol) and D share receptor pathways and work synergistically at appropriate ratios.
Toxicity threshold: Vitamin D toxicity (hypercalcemia) generally requires sustained intake above 10,000 IU/day AND 25(OH)D above 100–150 ng/mL; rare exceptions: granulomatous diseases (sarcoidosis, TB) or CYP24A1 mutations cause hypersensitivity at lower doses; routine supplementation at 2,000–5,000 IU/day is safe for most adults with normal renal function; monitor annually with 25(OH)D testing.
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.